SUVRETTA CAPITAL MANAGEMENT, LLC - 30 Jun 2025 SCHEDULE 13G Report for Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX)

Filing Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager
Suvretta Capital Management, LLC
Security
Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
CMPX
Shares outstanding
137,490,250 shares
Disclosed Ownership
7,149,493 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
13 Aug 2025, 20:21:30 UTC
Date of event
30 Jun 2025
Next filing
21 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 5.2% ownership in Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX) on 30 Jun 2025."

Quick Takeaways

  • SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G for Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX).
  • Disclosed ownership: 5.2%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Aug 2025, 20:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Suvretta Capital Management, LLC 5.2% 7,149,493 0 7,149,493 /s/ Andrew Nathanson Andrew Nathanson/General Counsel and Chief Compliance Officer
Averill Master Fund, Ltd. 4.5% 6,251,950 0 6,251,950 /s/ Andrew Nathanson Andrew Nathanson/Authorized Signatory
Aaron Cowen 5.2% 7,149,493 0 7,149,493 /s/ Aaron Cowen Aaron Cowen

Sponsored